Multiomics approach identifies SERPINB1 as candidate progression biomarker for Spinocerebellar Ataxia type 2
Luis Enrique Almaguer-Mederos, Jana Key, NE Sen, Júlia Canet-Pons, Claudia Döring, David Meierhofer, Suzana Gispert-Sánchez, Dany Cuello‐Almarales, Dennis Almaguer‐Gotay, Lidia Matilde Osorio González, Raúl Aguilera‐Rodríguez, Jacqueline Medrano Montero, Georg W. J. Auburger
The paper identifies SERPINB1 as a potential biomarker for SCA2 progression through multi-omics analysis in mice and validation in human patients.
bioRxiv · Apr 18, 2025 · PreprintMolecular Biology